To obtain copies of these publications, please contact the Haematological Department
Phone (02) 8382-9142
Equivalent Survival for Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation, 2007, 13, 601-607 Moore, J, Nivison-Smith, I, Goh, K, Ma, D, Bradstock, K, Szer, J, Durrant, S, Schwarer, A, Bardy, P, Herrman, R, Dodds, A.
Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial. Am Heart J, 2008; 156(5): 954-63. JC Kovacic, P Macdonald, MP Feneley, DW Muller, J Freund, A Dodds, S Milliken, H Tao, S Itescu, J Moore, D Ma, and RM Graham.
Late Mortality and Relapse following BuCy2 and HLA-Identical Sibling Marrow Transplantation for Chronic Myelogenous Leukemia. Biol Blood Marrow Transplant. 2009, 15, 851-855 Edward A. Copelan, Pamela Ann Crilley, Jeffrey Szer, Anthony J. Dodds, Dustin Stevenson, Gary Phillips, Patrick Elder, Ian Nivison-Smith, Belinda R. Avalos, Sam Penza, David Topolsky, Ronald Sobecks, Matt Kalaycio, Brian J. Bolwell.
Emergency Department Haematology in: Emergency Medicine. The Principles of Practice, 5th edition. Churchill Livingstone. Ed. Gordian Fulde. 2009; Ch.43: 687-696 Dodds A
Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates. Biol Blood Marrow Transplant 2009; 15: 1323 – 1330. Nivison-Smith I, Simpson JM, Dodds AJ, Ma DDF, Szer J, Bradstock KF.
Extracorporeal Photopheresis for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation, Bone Marrow Transplant, Jun 2010; 45(6): 1068-76. Paul J Shaughnessy,, Brian J Bolwell, Koen van Besien, Martin Mistrik, Andrew Grigg, Anthony Dodds,, H Miles Prince, Simon Durrant,, Osman Ilhan, Dennis Parenti,, Jon Rogers, Jose Gallo, Francine Foss, Jane Apperley, Mei-Jie Zhang, Mary M Horowitz, MD, , Suni Abhyankar:
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia. Br J Haematol, Feb 2010; 148(4): 623-6 Shubham Pant, Mehdi Hamadani, Anthony J Dodds, Jeffrey Szer, Pamela A Crilley, Dustin Stevenson, Gary Phillips, Patrick Elder, Ian Nivison-Smith, Belinda R Avalos, Sam Penza, David Topolsky, Ronald Sobecks, Matt Kalaycio, Brian J Bolwell, and Edward A Copelan.
Increased activity and improved outcome in unrelated donor hematopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005 Intern Med J, 2011;41:27-34. .I Nivison-Smith, AJ Dodds, H Dunckley, DD Ma, JJ Moore, JM Simpson, J Szer, and KF Bradstock
Allogeneic hematopoietic cell transplantation for multiple myeloma using reduced intensity conditioning therapy, 18-2006, factors associated with improved survival outcome. Leukemia & Lymphoma, September 2011; 52(9): 1727–1735 I Nivison-Smith, A Dodds, R Doocey et al.
Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk. Biol Blood Marrow Transplant 2012; 18(2):302-308 Nivison-Smith I, Dodds AJ, Butler J, Bradstock KF, Ma DDF, Simpson JM, Szer J.